|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 51/10 | |
| C07K 16/32 | |||
| C07C 259/06 |
| (11) | Number of the document | 2496270 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10776064.7 |
| Date of filing the European patent application | 2010-11-04 | |
| (97) | Date of publication of the European application | 2012-09-12 |
| (45) | Date of publication and mention of the grant of the patent | 2018-01-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/055465 |
| Date | 2010-11-04 |
| (87) | Number | WO 2011/056983 |
| Date | 2011-05-12 |
| (30) | Number | Date | Country code |
| 612912 | 2009-11-05 | US |
| (72) |
GILL, Herman, US
JUNUTULA, Jagath R., US
LOWMAN, Henry B., US
MARIK, Jan, US
TINIANOW, Jeff, US
WILLIAMS, Simon, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | ZIRCONIUM-RADIOLABELED, CYSTEINE ENGINEERED ANTIBODY CONJUGATES |
| ZIRCONIUM-RADIOLABELED, CYSTEINE ENGINEERED ANTIBODY CONJUGATES |